Abstract
Introduction
The major biological function of vitamin D is to maintain normal blood levels of calcium and phosphorus. Vitamin D aids in the absorption of calcium, helping to form and maintain strong bones, thereby preventing rickets in children (1) . Vitamin D 3 (cholecalciferol) is generated in the skin of animals when a precursor molecule, 7-dehydrocholesterol, absorbs UV light energy. Thus, vitamin D is not a true vitamin because individuals with adequate exposure to sunlight do not require dietary supplementation. Infant formulas are typically fortified with vitamin D 3 , and less commonly vitamin D 2 , and are subject to strict regulatory control (2) .
Accurate, precise, rapid, high-throughput analytical methods for vitamin D are needed for routine testing to ensure that products are manufactured within tight product specifications. Additionally, reference methods utilizing contemporary techniques are needed to guarantee product compliance with global regulations.
The described method was developed to provide an accurate, rapid, and robust technique for the routine compliance testing of vitamin D 3 in infant formulas and adult/pediatric nutritional formulas and was recently reported (3) . To meet the requirements specified in the applicability statement of the vitamin D Standard Method Performance Requirements (SMPR; 4), the scope of the analysis was extended to include vitamin D 2 
A. Principle
Samples are saponified at high temperature; then lipid-soluble components are extracted into isooctane. A portion of the isooctane layer is transferred and washed, and an aliquot of 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) is added to derivatize vitamin D to form a high-molecular-mass, easily ionizable adduct. The vitamin D adduct is then re-extracted into a small volume of acetonitrile and analyzed by RPLC. Detection is by MS using multiple reaction monitoring (MRM). Stable isotope-labeled (SIL) d6-vitamin D 2 and d6-vitamin D 3 internal standards are used for quantitation to correct for losses in extraction and any variation in derivatization and ionization efficiencies.
B. Apparatus
(1) Ultra-HPLC (UHPLC) system.-Nexera (Shimadzu, Kyoto, Japan) or equivalent LC system consisting of a dual pump system, a sample injector unit, a degasser unit, and a column oven. 
D. Reagent Preparation
(1) PTAD solution (10 mg mL -1 ).-To a 5 mL volumetric flask, add 50 mg PTAD, then add 4 mL acetone, and dissolve; dilute to volume with acetone. Expiry: 1 day. 
F. Sample Preparation
Because vitamin D is sensitive to light, perform all steps under UV-shielded lighting.
(1) Powder sample preparation.-Accurately weigh 1.8-2.2 g powder sample into a boiling tube.
Record the weight. 
G. Extraction and Derivatisation
(1) To a powder, slurry, or liquid sample in a boiling tube, add 10 mL ethanolic pyrogallol solution, then add 0.5 mL SILIS, and then cap and vortex mix.
(2) Add 2 mL potassium hydroxide solution to the boiling tube; cap and vortex mix. 
H. Chromatography
(1) Set up the UHPLC system with the configuration shown in Table 2016 .05B.
(2) Form gradients by high-pressure mixing of the two mobile phases, A and B, using the procedure in Table 2016 .05C. 
I. Mass Spectrometry
(1) Set up the mass spectrometer with the instrument settings in Table 2016 .05D.
(2) The specific compound parameters to be used are listed in Tables 2016.05E and 2016.05F. ).
Published ).
K. Data Handling
Report result as µg hg -1 to one decimal place or as IU hg -1 to zero decimal places.
Results and Discussion

Method Optimization
The advantages of using the described derivatization strategy for the analysis of vitamin D are that many compounds (such as plant sterols) that are isobaric with vitamin D2 and vitamin D3 are excluded from detection because they lack the conjugated diene structure, and therefore do not form adducts. The derivatization of vitamin D with PTAD produces two epimers, 6S and 6R, because PTAD reacts with the cis-diene moiety from both the α-side and the β-side, with the ratio of 6S:6R being approximately 4:1 (6). The 6S/6R epimers co-elute using the described chromatographic conditions, and the typical MRM chromatograms for a sample are shown in Figures 1 and 2 . 
Single-Laboratory Validation
A wide range of infant formula and adult nutritional products that are available in the SPIFAN kit, plus an in-house vitamin D 3 QC milk powder sample, were used for the validation of this method (Table 1) .
Linearity was evaluated by the analysis of six-level calibration standards on three different days.
Visual inspection of the linear regression lines and residuals plots, back-calculation of standard concentrations (data not shown), and regression equations and correlation coefficients (Table 2) were used to demonstrate a linear relationship between instrument response and analyte concentration over the working range specified in the SMPR. The linear ranges for vitamin D 2 and vitamin D 3 extended beyond both the lower limit and the upper limit of the range specified in the vitamin D SMPR.
Precision was assessed for all of the fortified samples by testing duplicate samples on six separate days by two different analysts on a single instrument, with fresh calibration standards and reagents being made each day (Table 3 ). The repeatability of the method for the SPIFAN kit samples ranged between 1.5 and 5.2%, which complied with the ≤11.0% limit set in the SMPR. The HorRat values were within acceptability criteria for repeatability of 0.3-1.3 (7) . Intermediate precision ranged between 3.1 and 7.9%, with a mean value of 5.5%, less than the 15% limit for reproducibility defined in the SMPR. (Table 4) , within the limits set in the SMPR of 90-110%. (Table 5 ). As part of initial method validation, the LC-MS/MS was evaluated for bias against an HPLC-UV method based on AOAC 2002.05 (8, 9) . A p (α = 0.05) of 0.09 indicates that there was no bias between the methods (Table 6 ). Bias against a certified reference material or a reference method is not a defined parameter within the SMPR. 
Vitamin D-Previtamin D Interconversion
Although the described method specifically detects vitamin D and not the pre-vitamin D isomer, the was equivalent for the sample analyte and the internal standard. For deuterated internal standards, the labeled site must be remote from the triene centre because of the difference in inter-conversion behaviour between the analyte and the internal standard (10) . To confirm this assumption, the effect of temperature on the final results was evaluated. Experiments were performed with saponification assessed in three different ways: (1) at 70°C for 1 h, according to the described method protocol; (2) at 20°C for 7.5 h; and (3) at 70°C for 7.5 h. A 7.5 h saponification was chosen because this is the time needed, as previously reported, for a pure solution of vitamin D to reach equilibrium with pre-vitamin D at 70°C (11) . Samples 1-6 and 13-18, which were saponified at 70°C, showed significantly lower absolute peak areas for the vitamin D-PTAD quantifier ion than samples 7-12, which were saponified at 20°C. This was as expected because a higher proportion of vitamin D is converted to pre-vitamin D at the elevated temperature. This effect was seen for both the analyte It has been demonstrated that separate detection and measurement of pre-vitamin D in this method was not necessary and that the results obtained would be consistent with the requirements of the SMPR.
